PeptideStack
5.2kquestions
20kanswers
220users

Does LDL-C tell me anything about hepatic fat on cagrilintide?

Asked 9 Oct 2025Modified 6 months agoViewed 27k times
30

Stated plainly: LDL-C · cagrilintide.

I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious.

My background is quantitative but not chemical, so I can follow an equation more easily than a hand-wave.

Is the standard explanation correct, and if so, what is the evidence for it?

liver-enzymes
liver-enzymes

ALT, AST, GGT and ALP: what they do and do not indicate about hepatic fat, why enzymes are a poor surrogate for histology, and where non-invasive…

91 questions
mash
mash

Metabolic dysfunction-associated steatohepatitis: histological endpoints, resolution without worsening fibrosis, fibrosis improvement by stage,…

56 questions
bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
amylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questions
shareeditfollowflag
EL
askedesben_lykke84k1589 Oct 2025
3Same situation here, so I will follow this one. – Dr_Jonas_Halvorsen 3 months ago
4Which analyte, and what reference interval did the laboratory print beside it? – e_dziedzic 5 months ago
add a comment

5 Answers

Accepted answer first, then by votes
28

Accepted answer

The honest answer is that mild elevation is very common, that it usually improves with weight loss, and that the exceptions are the reason anyone checks.

Hy's law describes the combination that matters: transaminases above three times the upper limit together with bilirubin above twice the upper limit and no cholestatic explanation. That combination is a signal; isolated mild transaminase elevation is not.

Headline results, principal programmes

TrialAgentnDurationPrimary result
STEP 1Semaglutide 2.4 mg1,96168 wk−14.9 % vs −2.4 % weight
STEP 2Semaglutide 2.4 mg, T2DM1,21068 wk−9.6 % vs −3.4 % weight
SURMOUNT-1Tirzepatide 5/10/15 mg2,53972 wk−15 / −19 / −21 % weight
SURMOUNT-4Tirzepatide, withdrawal67088 wkContinued loss vs substantial regain
SELECTSemaglutide 2.4 mg17,604~40 moMACE HR 0.80 (0.72–0.90)
FLOWSemaglutide 1.0 mg, CKD3,533~3.4 yrRenal composite reduced; stopped early
SURMOUNT-OSATirzepatide, OSA46952 wkAHI reduced with and without PAP

Concretely, very rapid weight loss can transiently worsen liver biochemistry, which is one of several arguments against pursuing the steepest possible trajectory.

Trials in this class have generally reported improvement rather than deterioration in liver biochemistry, consistent with the weight-mediated mechanism.

Research-use material of unknown content is an unquantifiable variable in any such attribution.

Isolated mild elevation is common and usually improves with weight loss.

shareimprove this answerflag
DB
answered · acceptedDr_Ingrid_Baumgartner73k5813 Dec 2025
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
24

Answering this needs the magnitude in multiples of the upper reference limit, because the thresholds that matter clinically are defined that way and not in absolute units.

Gamma-glutamyl transferase is sensitive and unspecific: it rises with alcohol, with several medications and with fatty liver, and an isolated elevation rarely changes anything on its own.

Stated carefully, weight loss of ten per cent or more typically reduces transaminases substantially in people whose elevation was driven by hepatic fat, which is the majority of mild elevations in this population.

Transaminases plus bilirubin plus alkaline phosphatase, or you have not measured enough to conclude anything.

shareimprove this answerflag
KA
answeredkwn_analytical147k3582 Dec 2025
3Is the assay method stated on your report? Two immunoassays for the same analyte do not agree with each other. – Dr_Yusuf_Adeyemi 9 months ago
2This should be linked from the help pages. – bufferline42 8 months ago
add a comment
13

More usefully, this is one of the areas where the trend across several measurements is far more informative than any single result.

Creatine kinase, alkaline phosphatase and bilirubin together tell you which compartment the abnormality is in, and ordering the transaminases alone throws that information away.

Put another way, an isolated result three weeks after starting anything is difficult to interpret. A baseline taken before starting makes the same result trivially interpretable, which is the argument for baselines.

Laboratory-specific reference intervals for transaminases vary enough that cross-laboratory comparison of borderline values is unreliable.

New training, alcohol and over-the-counter products first. Then the interesting hypotheses.

edited 27 Dec 2025 by Dr_Idris_Coulibaly — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
DC
answeredDr_Idris_Coulibaly33k13724 Dec 2025
10

The relevant caution is that a rapid rise, particularly with bilirubin, is a different event from a stable mild elevation and needs handling differently.

Alanine aminotransferase is relatively liver-specific; aspartate aminotransferase is also present in muscle, heart and red cells. A raised AST with a normal ALT after heavy resistance training is usually muscle, and creatine kinase settles the question.

The caveat is direct: rising liver enzymes with jaundice, dark urine or right-upper-quadrant pain is a same-day clinical problem, not a forum question.

Get a baseline before you start anything, because it converts an uninterpretable result into an interpretable one for the cost of one blood draw.

edited 26 Jan 2026 by fib4_reader — added the placebo-arm figures

shareimprove this answerflag
FR
answeredfib4_reader24k274 Jan 2026
7

Start with the pattern. A hepatocellular pattern with alanine aminotransferase above aspartate aminotransferase points one way; a cholestatic pattern with alkaline phosphatase and gamma-glutamyl transferase points another.

Reference upper limits around forty units per litre for ALT are conventional rather than physiological; several groups have argued for limits closer to thirty for men and twenty-five for women.

Read the pattern before the magnitude, and the magnitude in multiples of the upper limit.

edited 10 Feb 2026 by lipid_panel_q — updated for the 2026 guidance change

shareimprove this answerflag
LQ
answeredlipid_panel_q36k12715 Jan 2026
7Confirming that a repeat two weeks later resolved what looked alarming on a single draw. – leah_ferrers 6 months ago
8Worth flagging that a mild enzyme elevation with a normal bilirubin is a different object from a rising one. – bufferline42 7 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.